Sameera Kumar, MD
Dr. Sameera Kumar is a radiation oncologist and assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania. She specializes in using innovative radiation therapy tools to treat thoracic malignancies including lung cancer, malignant pleural mesothelioma, thymoma, and esophageal cancer.[1]
Dr. Kumar works as part of a multidisciplinary care team at Fox Chase, collaborating with physicians from the departments of surgery, medical oncology, diagnostic imaging, and pathology as well as other cancer care specialists including nurses, nurse navigators, genetic counselors, social workers, physical therapists, and hospital pharmacists. She believes that working together in this way is the key to creating the most successful treatment plan and providing patients with the best possible outcome to match their condition and their goals.[1]
Education and Career
After earning her medical degree at West Virginia University School of Medicine in Morgantown, West Virginia, Dr. Kumar completed her internship and residency in radiation oncology at the University of Kentucky in Lexington, Kentucky. She was named Chief Resident during her final years there and began pursuit of her Ph.D. in Clinical and Translational Science. She was recruited to join the Fox Chase Cancer Center’s Department of Radiation Oncology immediately upon completion of her residency. Dr. Kumar is board-certified in Radiation Oncology.[1]
Research
Dr. Kumar’s primary research interests include the management of ultra-central early-stage non-small cell lung cancer tumors and the application of hypofractionation to thoracic malignancies.
Dr. Kumar’s publications include:[1]
- Real-world Use of Radiation for Newly Diagnosed Brain Metastases in Patients With ALK-positive Lung Cancer Receiving First-line ALK Inhibitor. Sameera Kumar, Xiaoliang Wang, Harlan Pittell, Gregory S Calip, Stephanie E Weiss, Joshua E Meyer, Trevor J Royce>; International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 15
- Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer. Kevin K Zarrabi, Thomas J Galloway, Douglas B Flieder, Sameera S Kumar, Julia Judd, Jessica R Bauman>; Head & Neck. 2022 Aug 1
- Radioresistance in Prostate Cancer: Focus on the Interplay between NF-κB and SODSameera Kumar, Daret K. St. Clair>; Antioxidants. 2021 Nov 30
- Kumar, S; Hall, L.; Li, X; Downes, L.; Shearer, A.; Shelton, B.; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.
- Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036
- Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197
- Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed
- Dong, L.; Kudrimoti, M; Irwin, D.; Chen, L.; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B.; Yu, G. “Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes,” J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.
- Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t.” Applied Radiology. February 2013.
